$IOVA 8-K/A SEC Filings

Filed On	Filing
02 Jun 2023	8-K/A: Financial Statements and Exhibits The following unaudited pro forma condensed combined financial statements present the combination of the historical financial statements of Iovance Biotherapeutics, Inc. (the “Company” or “Iovance”), and Clinigen SP Limited (a carve-out ...
27 Jan 2023	8-K/A: Financial Statements and Exhibits CERTAIN CONFIDENTIAL PORTIONS OF THIS EXHIBIT HAVE BEEN OMITTED AND REPLACED WITH “[***]”. SUCH IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS (I) NOT MATERIAL AND (II) the registrant customarily and actually tr...
09 Dec 2014	8-K/A: Submission of Matters to a Vote of Security Holders
22 Mar 2012	8-K/A: Departure/Election of Directors or Officers; Compensation
06 Feb 2012	8-K/A: Entry into a Material Definitive Agreement
20 Jan 2012	8-K/A: Entry into a Material Definitive Agreement
10 Jan 2012	8-K/A: Entry into a Material Definitive Agreement
22 Dec 2011	8-K/A: Entry into a Material Definitive Agreement
13 Dec 2011	8-K/A: Financial Statements and Exhibits
29 Nov 2011	8-K/A: Financial Statements and Exhibits
13 Oct 2011	8-K/A: Financial Statements and Exhibits
06 Jul 2010	8-K/A: Entry into a Material Definitive Agreement; Completion of Acquisition or Disposition of Assets +1 more
16 Sep 2009	8-K/A: Changes in Registrant's Certifying Accountant
25 Aug 2009	8-K/A: Changes in Registrant's Certifying Accountant

Comments